Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000997013 | SCV001152069 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | CNOT3: BS1 |
Mendelics | RCV002249603 | SCV002518117 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000997013 | SCV002952718 | likely benign | not provided | 2023-08-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002550705 | SCV003560820 | likely benign | Inborn genetic diseases | 2022-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
University of Washington Center for Mendelian Genomics, |
RCV001261735 | SCV001439051 | likely pathogenic | Moyamoya angiopathy with developmental delay | no assertion criteria provided | research | ||
Diagnostic Laboratory, |
RCV000997013 | SCV001978574 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000997013 | SCV001979889 | likely benign | not provided | no assertion criteria provided | clinical testing |